Lilly China
- PES
- Jul 22
- 1 min read
PES is providing C&Q services to Lilly at their site in Suzhou, China, as part of a site expansion to enable the increased production of innovative medicines for type 2 diabetes and obesity.
We continue to work with Lilly in Asia, Europe and the United States to support their ongoing capital projects.
